BNT162b2 Protection against the Omicron Variant in Children and Adolescents

Overview of attention for article published in New England Journal of Medicine, March 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 4 public wall posts from 4 users.

USA: Impfstoffe haben in der Omikron-Welle hohe Schutzwirkung bei Kindern…

BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age.

BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age.

BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age.

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.